戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 g lymph node (LN)-homing of immune cells via afferent lymphatics.
2 4 were involved in their trafficking through afferent lymphatics.
3  cells from tissues into lymph nodes through afferent lymphatics.
4 ode trafficking of dendritic cells (DCs) via afferent lymphatics.
5 ls and induced Treg migrated normally toward afferent lymphatics.
6   Thus, T-bet regulates nTreg migration into afferent lymphatics and dLN and consequently their suppr
7 the foot pad or ear pinnae, and migration to afferent lymphatics and dLN quantified by flow cytometry
8 F-C were lost upon cauterization of the dCLN afferent lymphatics and not mimicked by acute post-strok
9  differences between human and murine dermal afferent lymphatics and provide a deeper understanding o
10 tivated CD4 T cells enter downstream LNs via afferent lymphatics at high frequencies.
11 ymph nodes (LNs) during immune responses via afferent lymphatic channels.
12                      In the small intestine, afferent lymphatics convey Ags and microbial signals to
13                                              Afferent lymphatic dendritic cells from sheep have been
14                                              Afferent lymphatics form CCL21 gradients to guide dendri
15 1 inhibited the entry of tissue T cells into afferent lymphatics in homeostatic and inflammatory cond
16 r in supporting lymphocyte migration via the afferent lymphatics into the draining lymph nodes.
17  interstitial fluid and small molecules from afferent lymphatics into the nodal parenchyma.
18                                           In afferent lymphatics, MRC mediates trafficking of both no
19 and tissues via high endothelial venules and afferent lymphatics, respectively, and formed interactio
20 phocytes most likely entered PLN through the afferent lymphatics, since they did not migrate into PLN
21 st migrate from blood to allograft, then via afferent lymphatics to draining LN to protect allografts
22 n leukocyte exit from peripheral tissues via afferent lymphatics to the draining lymph node remains p
23 a framework for understanding the effects of afferent lymphatic transport on immune surveillance, per
24 DCs in the draining LNs revealed a temporary afferent lymphatic vessel (LV) functional insufficiency.
25                Finally, using human sentinel afferent lymphatic vessel explants, we demonstrated that
26                                              Afferent lymphatic vessels (LVs) are present in most vas
27                               Cannulation of afferent lymphatic vessels allows the isolation of large
28 t dendritic cells (DCs) constitutively enter afferent lymphatic vessels in many organs and that DCs i
29 rom peripheral tissues by cannulation of the afferent lymphatic vessels provides DC which can be used
30                  Over a period of 6-8 weeks, afferent lymphatic vessels re-anastomose with the effere
31 lymphatics to normal and prearthritic knees, afferent lymphatic vessels to collapsed LNs in inflamed
32 and migrate from the injection site, via the afferent lymphatic vessels, into the local lymph node.
33 ns and the migration of dendritic cells into afferent lymphatic vessels.
34 s that enter the lymph node through upstream afferent lymphatic vessels.
35 urvey tissues and migrate to lymph nodes via afferent lymphatic vessels.